A Unique Compounding Treatment For Porokeratosis

iStock-925710280 Copy
iStock-925710280 Copy 2
iStock-9257102802

Pavilion Compounding Pharmacy is pleased to provide a unique and effective topical treatment for porokeratosis, associated with mevalonate pathway gene mutations. 


With limited treatment options for this condition, a combination of cholesterol and a statin drug, like lovastatin or simvastatin, has shown positive results. According to the Journal of the American Academy of Dermatology, the study of the combination when applied to the skin has proven efficacy with no adverse side effects documented
[ORIGINAL ARTICLE| VOLUME 82, ISSUE 1, P123-131, JANUARY 01, 2020].


Pavilion Compounding Pharmacy uses the latest compounding technology to formulate the treatment in a combination of two penetration enhancing and non-aqueous bases to achieve an extraordinary level of effectiveness.  We have received very positive therapeutic outcomes  and feedback from our patients due to the formulation. 


Pavilion Compounding pharmacists are happy to discuss our formulation with your provider.  Our PCAB accredited laboratory offers both pick up and shipping to several states, including GA, FL, NC, SC, KY, TN, NY, NJ. Within our Atlanta Metro Area, we have cost-effective shipping options and also on demand delivery if needed. Your provider can fax, e-scribe, or phone your order to us for completion.

 

Pavilion Compounding Pharmacy is located in Atlanta, GA within the Buckhead area.
3200 Downwood Circle, NW Suite 210
Atlanta, GA 3032
P: 404-350-5780
F: 404-350-5640
staff@pavilionrx.com

Ointment Mill for Dermatology

An ointment mill in use to provide reduced particle sizes and a smooth, elegant formulation for a unique compounding treatment for porokeratosis.